Detalhe da pesquisa
1.
Seroconversion after SARS-CoV-2 vaccination is protective against severe COVID-19 disease in heart transplant recipients.
Immun Inflamm Dis
; 11(11): e1086, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38018598